US BANCORP \DE\ - LYRA THERAPEUTICS INC ownership

LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 38 filers reported holding LYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of LYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,955
-4.9%
5000.0%0.00%
Q2 2023$2,055
+104.5%
5000.0%0.00%
Q1 2023$1,005
-36.0%
5000.0%0.00%
Q4 2022$1,570
-47.7%
5000.0%0.00%
Q3 2022$3,0000.0%5000.0%0.00%
Q2 2022$3,000
+50.0%
5000.0%0.00%
Q1 2022$2,0000.0%5000.0%0.00%
Q4 2021$2,000
-60.0%
5000.0%0.00%
Q3 2021$5,000
+25.0%
5000.0%0.00%
Q2 2021$4,000
-33.3%
5000.0%0.00%
Q1 2021$6,000
+100.0%
500
+66.7%
0.00%
Q3 2020$3,0000.0%3000.0%0.00%
Q2 2020$3,0003000.00%
Other shareholders

There were no reported owners of LYRA THERAPEUTICS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of LYRA THERAPEUTICS INC shareholders